Cisternal sustained release dihydropyridines for subarachnoid hemorrhage

Current Neurovascular Research

Volumn 9, Issue 2, 2012, Pages 139-148

  Cook, Douglas J ^a,b   Kan, Sabrina ^a,b   Ai, Jinglu ^a,b   Kasuya, Hidetoshi ^a,b   Macdonald, R Loch ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Dihydropyridine; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

MIBEFRADIL; NICARDIPINE; NIMODIPINE; PLACEBO; POLYGLACTIN;

ANGIOGRAPHY; ANIMAL TISSUE; ANTERIOR CEREBRAL ARTERY; ARTERY CATHETER; ARTICLE; BASILAR ARTERY; BLOOD CLOT; BRAIN INFARCTION; BRAIN VASOSPASM; CEREBROSPINAL FLUID LEVEL; CISTERNA MAGNA; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; FEMALE; HISTOLOGY; INTERNAL CAROTID ARTERY; MACACA; MICROTHROMBUS; MIDDLE CEREBRAL ARTERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STUDENT T TEST; SUBARACHNOID HEMORRHAGE; SUSTAINED DRUG RELEASE;

EID: 84860726777     PISSN: 15672026     EISSN: 18755739     Source Type: Journal    
DOI: 10.2174/156720212800410894     Document Type: Article

References (34)

1. Pluta RM, Hansen-Schwartz J, Dreier J, et al. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res 2009; 31(2): 151-8.
2. Dorhout Mees SM, Rinkel GJ, Feigin VL, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007; (3): CD000277.
3. Kasuya H, Kawashima A, Sasahara A, et al. Development of nicardipine prolonged-release implants for preventing vasospasm. Acta Neurochir Suppl 2001; 77: 217-20. (Pubitemid 33759251)
4. Kasuya H, Onda H, Sasahara A, et al. Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 2005; 56(5): 895-902.
5. Barth M, Capelle HH, Weidauer S, et al. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 2007; 38(2): 330-6. (Pubitemid 46188258)
6. Etminan N, Vergouwen MD, Ilodigwe D, et al. Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab 2011; 31(6): 1443-51.
7. Vergouwen MD, Etminan N, Ilodigwe D, et al. Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab 2011; 31(7): 1545-53.
8. Dreier JP, Windmuller O, Petzold G, et al. Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/ hemodilution in rats. Neurosurgery 2002; 51(6): 1457-65.
9. Vergouwen MD, Vermeulen M, Coert BA, et al. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 2008; 28(11): 1761-70.
10. Takahashi M, Zhang ZD, Macdonald RL, et al. Sphenopalatine ganglion stimulation for vasospasm after experimental subarachnoid hemorrhage. J Neurosurg 2011; 114(4): 1104-9.
11. Macdonald RL, Curry DJ, Aihara Y, et al. Magnesium and experimental vasospasm. J Neurosurg 2004; 100(1): 106-10. (Pubitemid 38017822)
12. Perkins E, Kimura H, Parent AD, et al. Evaluation of the microvasculature and cerebral ischemia after experimental subarachnoid hemorrhage in dogs. J Neurosurg 2002; 97(4): 896-904. (Pubitemid 35222413)
13. Kawashima A, Kasuya H, Sasahara A, et al. Prevention of cerebral vasospasm by nicardipine prolonged-release implants in dogs. Neurol Res 2000; 22(6): 634-41.
14. Nikitina E, Kawashima A, Takahashi M, et al. Alteration in voltage-dependent calcium channels in dog basilar artery after subarachnoid hemorrhage. Laboratory investigation. J Neurosurg 2010; 113(4): 870-80.
15. 2+ channel antagonist mibefradil (Ro 40-5967). Mol Pharmacol 1995; 48(3): 540-9.
16. Jensen LJ, Salomonsson M, Jensen BL, et al. Depolarizationinduced calcium influx in rat mesenteric small arterioles is mediated exclusively via mibefradil-sensitive calcium channels. Br J Pharmacol 2004; 142(4): 709-18. (Pubitemid 38969666)
17. Ishiguro M, Wellman TL, Honda A, et al. Emergence of a R-type Ca2+ channel (CaV 2.3) contributes to cerebral artery constriction after subarachnoid hemorrhage. Circ Res 2005; 96(4): 419-26. (Pubitemid 40354535)
18. Kasuya H, Onda H, Takeshita M, et al. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke 2002; 33(4): 1011-5. (Pubitemid 34293584)
19. Krischek B, Kasuya H, Onda H, et al. Nicardipine prolongedrelease implants for preventing cerebral vasospasm after subarachnoid hemorrhage: effect and outcome in the first 100 patients. Neurol Med Chir (Tokyo) 2007; 47(9): 389-94. (Pubitemid 47535629)
20. Barth M, Pena P, Seiz M, et al. Feasibility of intraventricular nicardipine prolonged release implants in patients following aneurysmal subarachnoid haemorrhage. Br J Neurosurg 2011; 25(6): 677-83.
21. Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 1989; 298: 636-42. (Pubitemid 19088521)
22. Haley ECJ, Kassell NF, Torner JC, et al. A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 1994; 80(5): 788-96. (Pubitemid 24129672)
23. Rabinstein AA, Friedman JA, Weigand SD, et al. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2004; 35(8): 1862-6. (Pubitemid 38971866)
24. Umredkar A, Gupta SK, Khandelwal N, et al. Intracerebral infarcts following clipping of intracranial aneurysms: incidence, clinical correlation and outcome. Br J Neurosurg 2010; 24(2): 156-62.
25. Crowley RW, Medel R, Dumont AS, et al. Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke 2011; 42(4): 919-23.
26. Laursen J, Jensen F, Mikkelsen E, et al. Nimodipine treatment of subarachnoid hemorrhage. Clin Neurol Neurosurg 1988; 90(4): 329-37. (Pubitemid 19016025)
27. Mohamed AA, McCulloch J, Mendelow AD, et al. Effect of the calcium antagonist nimodipine on local cerebral blood flow: relationship to arterial blood pressure. J Cereb Blood Flow Metab 1984; 4(2): 206-11. (Pubitemid 14080149)
28. Porchet F, Chiolero R, de Tribolet N, et al. Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage. Acta Neurochir 1995; 137(1-2): 62-9.
29. Stein SC, Browne KD, Chen XH, et al. Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study. Neurosurgery 2006; 59: 781-7. (Pubitemid 44579595)
30. Dreier JP, Major S, Manning A, et al. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain 2009; 132(Pt 7): 1866-81.
31. Lewis PJ, Weir BK, Nosko MG, et al. Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm. Neurosurgery 1988; 22(3): 492-500. (Pubitemid 18095951)
32. Hanggi D, Turowski B, Perrin J, et al. The effect of an intracisternal nimodipine slow-release system on cerebral vasospasm after experimental subarachnoid haemorrhage in the rat. Acta Neurochir Suppl (Wien) 2008; 104: 103-7.
33. Hanggi D, Beseoglu K, Turowski B, et al. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasmrefractory to medical and endovascular therapy. Clin Neurol Neurosurg 2008; 110(8): 784-90.
34. Hanggi D, Eicker S, Beseoglu K, et al. Dose-related efficacy of a continuous intracisternal nimodipine treatment on cerebral vasospasm in the rat double subarachnoid hemorrhage model. Neurosurgery 2009; 64(6): 1155-9.